L'Occitane International Owner Nearing Deal to Go Private with Funding from Blackstone, Bloomberg Reports
By Denny Jacob
--L'Occitane International owner Reinold Geiger is nearing a deal to take the skin-care company private with funding help from Blackstone, reports Bloomberg, citing people familiar with the matter.
--The alternative asset manager may provide debt financing for the buyout, according to the report. An announcement may come in the coming days, it added.
--Geiger, who is considering a 20% premium of over 26 Hong Kong dollars ($3.32) a share, has lined up financing for the deal, according to Bloomberg.
--While deliberations are at an advanced stage, no final decisions have been made and talks could still be delayed or even fall apart, according to the report.
Full story at https://www.bloomberg.com/news/articles/2024-04-09/blackstone-said-to-near-buyout-of-skin-care-company-l-occitane?srnd=homepage-americas
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 09, 2024 11:17 ET (15:17 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks